国产与进口瑞格列奈片治疗2型糖尿病的成本-效果分析

Cost-effectiveness analysis of domestic vs imported repaglinid tablets in treatment of type 2 diabetes mellitus

目的比较国产与进口瑞格列奈片治疗2型糖尿病的成本-效果。方法按照给药方案分为孚来迪组(国产药物)和诺和龙组(进口药物)2组,运用药物经济学原理进行成本-效果比较。结果2组给药方案治疗2型糖尿病均疗效相近,但成本间却存在显著差异。结论国产比进口瑞格列奈片具有较好的成本-效果比。

Objective To evaluate the cost -effectiveness of domestic versus imported repaglinid tablets in the treatment of type 2 diabetes meilitus. Methods Based on the medication data for type 2 diabetes meilitus,patients with type 2 diabetes mellitus were assigned to receive domestic repaglinid tablets or imported repaglinid tablets. The cost - effectiveness of the two medicaments in the two groups were compared based on the theory of pharmacoeconomics. Results Domestic and imported repaglinid showed the same effectiveness for type 2 diabetes mellitus, while the costs in the two groups were significantly different. Conclusions Compared with imported repaglinid, the domestic repaglinid has high cost- effectiveness ratio.